I kontrollerede kliniske studier forekom angioødem sjældent under behandling med aliskiren, og havde sammenlignelig incidens med placebo eller hydrochlorthiazid.
In controlled clinical trials, angioedema occurred rarely during treatment with aliskiren with rates comparable to treatment with placebo or hydrochlorothiazide.